Armata Pharmaceuticals (ARMP) Free Cash Flow: 2013-2018
Historic Free Cash Flow for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$3.6 million.
- Armata Pharmaceuticals' Free Cash Flow fell 50.23% to -$3.6 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$11.2 million, marking a year-over-year decrease of 20.79%. This contributed to the annual value of -$39.4 million for FY2024, which is 29.04% up from last year.
- Per Armata Pharmaceuticals' latest filing, its Free Cash Flow stood at -$3.6 million for Q4 2018, which was down 64.87% from -$2.2 million recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Free Cash Flow registered a high of -$626,000 during Q3 2017, and its lowest value of -$3.9 million during Q1 2014.
- In the last 3 years, Armata Pharmaceuticals' Free Cash Flow had a median value of -$3.0 million in 2016 and averaged -$2.6 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first slumped by 250.31% in 2014, then spiked by 80.19% in 2017.
- Over the past 5 years, Armata Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$3.2 million in 2014, then rose by 26.15% to -$2.4 million in 2015, then skyrocketed by 36.16% to -$1.5 million in 2016, then tumbled by 57.97% to -$2.4 million in 2017, then tumbled by 50.23% to -$3.6 million in 2018.
- Its last three reported values are -$3.6 million in Q4 2018, -$2.2 million for Q3 2018, and -$1.9 million during Q2 2018.